Getting Ready for a Biopharma Partnering Deal
6 ArticlesLicensing & Partnering ×
What's Hot and What's Not in Oncology Licensing in 2020?
Predictable Failure (And How to Avoid It) for Early-Stage Life Science Companies
In this webinar, Dr. Lucia Mokres breaks down the six major stakeholder categories relevant to most life science companies, and shares key strategies for closing the knowledge gap between founders and their market success.
Essential Steps to Successful BioPharma Partnering
What's Hot & What's Not in Antibody Drug Conjugates Licensing
In this webinar, learn what targets are suitable, what are the trends in linkers and the drugs to be attached to the antibodies, how are companies dealing with the complexities of internalization and high cost of goods, what kind of data will drive an ADC licensing deal, how do the ADCs fit in the world of immuno-oncology and what is the future for ADCs.